Llaama
Patient digital twins and traceable healthcare software for hospitals, clinics, pharmaceutical companies and research organisations
Highlights
- New on EvolcAdded 2026-11-03
About Llaama
LLAAMA develops Patient Digital Twins: digital companions that support patients through surgery, chronic illness and clinical studies. Its T2R2 software engine provides traceable and reproducible data and AI workflows, with human oversight built into care-related decisions.
Its customers include hospitals, clinics, pharmaceutical companies, contract research organisations, biotechs and medical-device software teams. The company also offers T2R2 as a platform for building regulated software.
LLAAMA SAS was founded in 2019 and is based in Rixheim, France. Its engine has been used in pharmaceutical research since 2020, and its first Patient Digital Twin deployment is live.
Product: Patient Digital Twin software for patient support and T2R2, a traceable engine for healthcare and pharmaceutical data and AI workflows.
Jobs at Llaama
Leadership
- Suzanne Studinger · CQO, co-founderSource: company website
- Bernard Deffarges · CEO, co-founderSource: company website
- Damien Hauser · CIO, co-founderSource: company website
More health & medtech companies
logicrdv.fr
Online medical appointment booking, agenda software and telesecretariat for healthcare practices in FranceNew on EvolcLogicsante
Healthcare management software and services for medical and paramedical centres and healthcare professionalsNew on EvolcLso Medical
Manufactures endovenous lasers and fibres for vascular practitioners treating varicose veinsNew on EvolcLucis
Preventive health membership with biomarker testing and year-round guidance for consumersRemote-friendlyLudocare
Digital pediatric therapies for children with chronic conditions, beginning with asthma care for childrenNew on EvolcLumeen
Therapeutic virtual reality systems and immersive content for healthcare and social care providersNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- ContentfulMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Frontend frameworks
- Next.jsHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Related technologyimplied by Next.js
- Tailwind CSSMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Hosting
- VercelHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-vercel-id
- Response headerx-vercel-id
- Response headerx-vercel-id
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
